Structured treatment interruptions to control HIV-1 and limit drug exposure
- 1 February 2001
- journal article
- review article
- Published by Elsevier in Trends in Immunology
- Vol. 22 (2) , 92-96
- https://doi.org/10.1016/s1471-4906(00)01809-3
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Immune control of HIV-1 after early treatment of acute infectionNature, 2000
- What is missing in immunology to understand immunity?Nature Immunology, 2000
- The role of CD4+ T helper cells in the cytotoxic T lymphocyte response to HIV-1Current Opinion in Immunology, 2000
- The CD4+ T cell response to HIV-1Current Opinion in Immunology, 2000
- Early highly active antiretroviral therapy for acute HIV-1 infection preserves immune function of CD8+and CD4+T lymphocytesProceedings of the National Academy of Sciences, 2000
- Resistance, Fitness, Adherence, and PotencyPublished by American Medical Association (AMA) ,2000
- Persistence of HIV-1 Transcription in Peripheral-Blood Mononuclear Cells in Patients Receiving Potent Antiretroviral TherapyNew England Journal of Medicine, 1999
- Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapyNature Medicine, 1999
- Vigorous HIV-1-Specific CD4 + T Cell Responses Associated with Control of ViremiaScience, 1997
- INFECTION-IMMUNITY IN EXPERIMENTAL SALMONELLOSISThe Journal of Experimental Medicine, 1966